Perceptive Advisors LLC Syndax Pharmaceuticals Inc Transaction History

Perceptive Advisors LLC

  • $3.83 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$13.42 - $25.18 $3.62 Million - $6.8 Million
-270,000 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$19.28 - $24.59 $578,400 - $737,700
-30,000 Reduced 10.0%
270,000 $6.04 Million
Q4 2020

Feb 16, 2021
BUY
$15.1 - $26.44 $4.53 Million - $7.93 Million
300,000 New
300,000 $6.67 Million

Others Institutions Holding SNDX

# of Institutions
229
Shares Held
88.4M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $933M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email